{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T12:35:49Z","timestamp":1791894949795,"version":"4.3.4"},"reference-count":100,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,5,26]],"date-time":"2026-05-26T00:00:00Z","timestamp":1779753600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,5,26]],"date-time":"2026-05-26T00:00:00Z","timestamp":1779753600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Biol Rep"],"published-print":{"date-parts":[[2026,12]]},"DOI":"10.1007\/s11033-026-11976-8","type":"journal-article","created":{"date-parts":[[2026,5,26]],"date-time":"2026-05-26T11:31:27Z","timestamp":1779795087000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Unveiling the anti-cancer properties of apigenin via targeting different molecular signatures: A Review"],"prefix":"10.1007","volume":"53","author":[{"given":"Deepika","family":"Bhagavatula","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ritu","family":"Raina","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Uzma","family":"Khan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huzefa","family":"Vahora","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lynn Clifford","family":"Dsouza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tom","family":"Sinoy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hussaina","family":"Banu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arif","family":"Hussain","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,5,26]]},"reference":[{"key":"11976_CR1","doi-asserted-by":"publisher","first-page":"10","DOI":"10.3322\/caac.21871","volume":"75","author":"RL Siegel","year":"2025","unstructured":"Siegel RL, Kratzer TB, Giaquinto AN et al (2025) Cancer statistics, 2025. CA Cancer J Clin 75:10\u201345. https:\/\/doi.org\/10.3322\/caac.21871","journal-title":"CA Cancer J Clin"},{"key":"11976_CR2","doi-asserted-by":"publisher","first-page":"768130","DOI":"10.3389\/fgene.2021.768130","volume":"12","author":"R Raina","year":"2021","unstructured":"Raina R, Almutary AG, Bagabir SA et al (2021) Chrysin Modulates Aberrant Epigenetic Variations and Hampers Migratory Behavior of Human Cervical (HeLa) Cells. Front Genet 12:768130. https:\/\/doi.org\/10.3389\/fgene.2021.768130","journal-title":"Front Genet"},{"key":"11976_CR3","doi-asserted-by":"publisher","unstructured":"Maniewska J, Je\u017cewska D (2021) Non-Steroidal Anti-Inflammatory Drugs in Colorectal Cancer Chemoprevention. Cancers (Basel) 13. https:\/\/doi.org\/10.3390\/cancers13040594","DOI":"10.3390\/cancers13040594"},{"key":"11976_CR4","doi-asserted-by":"publisher","first-page":"188","DOI":"10.4103\/ijd.ijd_805_24","volume":"70","author":"A Ghosh","year":"2025","unstructured":"Ghosh A, Chatterjee S, Dawn A, Das A (2025) HPV Vaccines - An Overview. Indian J Dermatol 70:188\u2013200. https:\/\/doi.org\/10.4103\/ijd.ijd_805_24","journal-title":"Indian J Dermatol"},{"key":"11976_CR5","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1007\/s10549-023-06991-3","volume":"201","author":"J Kotsopoulos","year":"2023","unstructured":"Kotsopoulos J, Gronwald J, Huzarski T et al (2023) Tamoxifen and the risk of breast cancer in women with a BRCA1 or BRCA2 mutation. Breast Cancer Res Treat 201:257\u2013264. https:\/\/doi.org\/10.1007\/s10549-023-06991-3","journal-title":"Breast Cancer Res Treat"},{"key":"11976_CR6","doi-asserted-by":"publisher","first-page":"e202300518","DOI":"10.1002\/cbic.202300518","volume":"24","author":"T-H Chen","year":"2023","unstructured":"Chen T-H, Lin H-C (2023) Terpene Synthases in the Biosynthesis of Drimane-Type Sesquiterpenes across Diverse Organisms. ChemBioChem 24:e202300518. https:\/\/doi.org\/10.1002\/cbic.202300518","journal-title":"ChemBioChem"},{"key":"11976_CR7","doi-asserted-by":"publisher","first-page":"192","DOI":"10.3892\/ol.2021.12452","volume":"21","author":"R Raina","year":"2021","unstructured":"Raina R, Pramodh S, Rais N et al (2021) Luteolin inhibits proliferation, triggers apoptosis and modulates Akt\/mTOR and MAP kinase pathways in HeLa cells. Oncol Lett 21:192. https:\/\/doi.org\/10.3892\/ol.2021.12452","journal-title":"Oncol Lett"},{"key":"11976_CR8","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1016\/j.jare.2024.02.023","volume":"68","author":"J Li","year":"2025","unstructured":"Li J, Zhang D, Wang S et al (2025) Baicalein induces apoptosis by inhibiting the glutamine-mTOR metabolic pathway in lung cancer. J Adv Res 68:341\u2013357. https:\/\/doi.org\/10.1016\/j.jare.2024.02.023","journal-title":"J Adv Res"},{"key":"11976_CR9","doi-asserted-by":"crossref","unstructured":"Ashrafizadeh M, Bakhoda MR, Bahmanpour Z et al (2020) Apigenin as Tumor Suppressor in Cancers: Biotherapeutic Activity, Nanodelivery, and Mechanisms With Emphasis on Pancreatic Cancer. Front Chem 15:8:829","DOI":"10.3389\/fchem.2020.00829"},{"key":"11976_CR10","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1186\/s12935-021-01888-x","volume":"21","author":"Z Javed","year":"2021","unstructured":"Javed Z, Sadia H, Iqbal MJ et al (2021) Apigenin role as cell-signaling pathways modulator: implications in cancer prevention and treatment. Cancer Cell Int 21:189. https:\/\/doi.org\/10.1186\/s12935-021-01888-x","journal-title":"Cancer Cell Int"},{"key":"11976_CR11","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1016\/j.canlet.2021.05.019","volume":"515","author":"Z-B Jiang","year":"2021","unstructured":"Jiang Z-B, Wang W-J, Xu C et al (2021) Luteolin and its derivative apigenin suppress the inducible PD-L1 expression to improve anti-tumor immunity in KRAS-mutant lung cancer. Cancer Lett 515:36\u201348. https:\/\/doi.org\/10.1016\/j.canlet.2021.05.019","journal-title":"Cancer Lett"},{"key":"11976_CR12","doi-asserted-by":"publisher","first-page":"1496664","DOI":"10.3389\/fphar.2024.1496664","volume":"15","author":"M Ou","year":"2024","unstructured":"Ou M, Deng Z, Shi Y et al (2024) Mechanism of Apigenin against breast cancer stem cells: network pharmacology and experimental validation. Front Pharmacol 15:1496664. https:\/\/doi.org\/10.3389\/fphar.2024.1496664","journal-title":"Front Pharmacol"},{"key":"11976_CR13","doi-asserted-by":"publisher","unstructured":"Nimal S, Kumbhar N, Saruchi et al (2024) Apigenin and its combination with Vorinostat induces apoptotic-mediated cell death in TNBC by modulating the epigenetic and apoptotic regulators and related miRNAs. Sci Rep 14. https:\/\/doi.org\/10.1038\/s41598-024-60395-x","DOI":"10.1038\/s41598-024-60395-x"},{"key":"11976_CR14","doi-asserted-by":"publisher","first-page":"1273993","DOI":"10.3389\/fphar.2023.1273993","volume":"14","author":"A Khan","year":"2023","unstructured":"Khan A, Khan A, Khan MA et al (2023) Phytocompounds targeting epigenetic modulations: an assessment in cancer. Front Pharmacol 14:1273993. https:\/\/doi.org\/10.3389\/fphar.2023.1273993","journal-title":"Front Pharmacol"},{"key":"11976_CR15","first-page":"1520","volume":"26","author":"LW Wattenberg","year":"1966","unstructured":"Wattenberg LW (1966) Chemoprophylaxis of carcinogenesis: a review. Cancer Res 26:1520\u20131526","journal-title":"Cancer Res"},{"key":"11976_CR16","first-page":"1332","volume":"35","author":"MB Sporn","year":"1976","unstructured":"Sporn MB, Dunlop NM, Newton DL, Smith JM (1976) Prevention of chemical carcinogenesis by vitamin A and its synthetic analogs (retinoids). Fed Proc 35:1332\u20131338","journal-title":"Fed Proc"},{"key":"11976_CR17","doi-asserted-by":"publisher","unstructured":"Shabbir U, Rubab M, Daliri EB-M et al (2021) Curcumin, Quercetin, Catechins and Metabolic Diseases: The Role of Gut Microbiota. Nutrients 13. https:\/\/doi.org\/10.3390\/nu13010206","DOI":"10.3390\/nu13010206"},{"key":"11976_CR18","doi-asserted-by":"publisher","first-page":"24751","DOI":"10.1021\/acsomega.4c01300","volume":"9","author":"D Bhagavatula","year":"2024","unstructured":"Bhagavatula D, Hasan TN, Vohra H et al (2024) Delineating the Antiapoptotic Property of Apigenin as an Antitumor Agent: A Computational and In Vitro Study on HeLa Cells. ACS Omega 9:24751\u201324760. https:\/\/doi.org\/10.1021\/acsomega.4c01300","journal-title":"ACS Omega"},{"key":"11976_CR19","doi-asserted-by":"publisher","DOI":"10.1021\/acs.jafc.5c09562","author":"AX Gao","year":"2025","unstructured":"Gao AX, Wang AX-Y, Wang Z-Q et al (2025) Profiling Class-Wide Bioactivities of Flavonoids While Minimizing Compound-Specific Effects Using an Equimolar Mixture Strategy. J Agric Food Chem. https:\/\/doi.org\/10.1021\/acs.jafc.5c09562","journal-title":"J Agric Food Chem"},{"key":"11976_CR20","doi-asserted-by":"publisher","first-page":"962","DOI":"10.1007\/s11095-010-0089-7","volume":"27","author":"S Shukla","year":"2010","unstructured":"Shukla S, Gupta S (2010) Apigenin: a promising molecule for cancer prevention. Pharm Res 27:962\u2013978. https:\/\/doi.org\/10.1007\/s11095-010-0089-7","journal-title":"Pharm Res"},{"key":"11976_CR21","doi-asserted-by":"publisher","unstructured":"Singh P, Yadav S, Mahor AK et al (2024) Depiction of new flavonoids from Nyctanthus arbor-tristis, their antimicrobial activity and drug-likeness prediction. Nat Prod Res 1\u201310. https:\/\/doi.org\/10.1080\/14786419.2024.2345757","DOI":"10.1080\/14786419.2024.2345757"},{"key":"11976_CR22","doi-asserted-by":"publisher","first-page":"1493","DOI":"10.1142\/S0192415X21500701","volume":"49","author":"SH Park","year":"2021","unstructured":"Park SH, Kim DS, Oh J et al (2021) Matricaria chamomilla (Chamomile) Ameliorates Muscle Atrophy in Mice by Targeting Protein Catalytic Pathways, Myogenesis, and Mitochondrial Dysfunction. Am J Chin Med (Gard City N Y) 49:1493\u20131514. https:\/\/doi.org\/10.1142\/S0192415X21500701","journal-title":"Am J Chin Med (Gard City N Y)"},{"key":"11976_CR23","doi-asserted-by":"crossref","unstructured":"Yan X, Qi M, Li P et al (2017) Apigenin in cancer therapy: Anti-cancer effects and mechanisms of action. Cell Biosci 7:50","DOI":"10.1186\/s13578-017-0179-x"},{"key":"11976_CR24","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1007\/s11010-012-1310-2","volume":"366","author":"H-S Seo","year":"2012","unstructured":"Seo H-S, Choi H-S, Kim S-R et al (2012) Apigenin induces apoptosis via extrinsic pathway, inducing p53 and inhibiting STAT3 and NF\u03baB signaling in HER2-overexpressing breast cancer cells. Mol Cell Biochem 366:319\u2013334. https:\/\/doi.org\/10.1007\/s11010-012-1310-2","journal-title":"Mol Cell Biochem"},{"key":"11976_CR25","doi-asserted-by":"publisher","unstructured":"Naponelli V, Rocchetti MT, Mangieri D (2024) Apigenin: Molecular Mechanisms and Therapeutic Potential against Cancer Spreading. Int J Mol Sci 25. https:\/\/doi.org\/10.3390\/ijms25105569","DOI":"10.3390\/ijms25105569"},{"key":"11976_CR26","doi-asserted-by":"publisher","unstructured":"Allemailem KS, Almatroudi A, Alharbi HOA et al (2024) Apigenin: A Bioflavonoid with a Promising Role in Disease Prevention and Treatment. https:\/\/doi.org\/10.3390\/biomedicines12061353. Biomedicines 12:","DOI":"10.3390\/biomedicines12061353"},{"key":"11976_CR27","unstructured":"Jing Fang 1 QZL-ZLCXXHXSB-HJ Apigenin inhibits tumor angiogenesis through decreasing HIF-1alpha and VEGF expression"},{"key":"11976_CR28","doi-asserted-by":"publisher","unstructured":"Rahmani AH, Alsahli MA, Almatroudi A et al (2022) The Potential Role of Apigenin in Cancer Prevention and Treatment. Molecules 27. https:\/\/doi.org\/10.3390\/molecules27186051","DOI":"10.3390\/molecules27186051"},{"key":"11976_CR29","doi-asserted-by":"publisher","first-page":"421","DOI":"10.32604\/or.2024.049757","volume":"33","author":"C He","year":"2025","unstructured":"He C, Zhang T, Xiong W et al (2025) Apigenin facilitates apoptosis of acute lymphoblastic leukemia cells via AMP-activated protein kinase-mediated ferroptosis. Oncol Res 33:421\u2013429. https:\/\/doi.org\/10.32604\/or.2024.049757","journal-title":"Oncol Res"},{"key":"11976_CR30","doi-asserted-by":"publisher","first-page":"3148","DOI":"10.2174\/1871520622666220426095257","volume":"22","author":"F Genc","year":"2022","unstructured":"Genc F, Atabey US, Serttas R, Erdogan S (2022) Abiraterone Acetate, in Combination with Apigenin, Attenuates the Survival of Human Castration-Sensitive Prostate Cancer Cells. Anticancer Agents Med Chem 22:3148\u20133156. https:\/\/doi.org\/10.2174\/1871520622666220426095257","journal-title":"Anticancer Agents Med Chem"},{"key":"11976_CR31","doi-asserted-by":"publisher","first-page":"125","DOI":"10.32471\/exp-oncology.2312-8852.vol-43-no-2.16096","volume":"43","author":"A Ayyildiz","year":"2021","unstructured":"Ayyildiz A, Koc H, Turkekul K, Erdogan S (2021) Co-administration of apigenin with doxorubicin enhances anti-migration and antiproliferative effects via PI3K\/PTEN\/AKT pathway in prostate cancer cells. Exp Oncol 43:125\u2013134. https:\/\/doi.org\/10.32471\/exp-oncology.2312-8852.vol-43-no-2.16096","journal-title":"Exp Oncol"},{"key":"11976_CR32","doi-asserted-by":"publisher","first-page":"2781","DOI":"10.21873\/anticanres.17647","volume":"45","author":"R Aida","year":"2025","unstructured":"Aida R, Okano K, Nakata K, Hagiwara H (2025) Apigenin-induced Apoptosis in Lung Adenocarcinoma A549 Cells: Involvement in IFNA2, TNF, and SPON2 With Different Time Points. Anticancer Res 45:2781\u20132790. https:\/\/doi.org\/10.21873\/anticanres.17647","journal-title":"Anticancer Res"},{"key":"11976_CR33","doi-asserted-by":"publisher","first-page":"4877","DOI":"10.3892\/mmr.2020.11572","volume":"22","author":"JS WOO","year":"2020","unstructured":"WOO JS, CHOO GS, YOO ES et al (2020) Apigenin induces apoptosis by regulating Akt and MAPK pathways in human melanoma cell A375SM. Mol. Med Rep 22:4877\u20134889","journal-title":"Med Rep"},{"key":"11976_CR34","doi-asserted-by":"publisher","unstructured":"Chen Y-H, Wu J-X, Yang S-F et al (2022) Anticancer Effects and Molecular Mechanisms of Apigenin in Cervical Cancer Cells. Cancers (Basel) 14. https:\/\/doi.org\/10.3390\/cancers14071824","DOI":"10.3390\/cancers14071824"},{"key":"11976_CR35","doi-asserted-by":"publisher","first-page":"539","DOI":"10.1007\/s11033-020-06087-x","volume":"48","author":"AK Shendge","year":"2021","unstructured":"Shendge AK, Chaudhuri D, Mandal N (2021) The natural flavones, acacetin and apigenin, induce Cdk-Cyclin mediated G2\/M phase arrest and trigger ROS-mediated apoptosis in glioblastoma cells. Mol Biol Rep 48:539\u2013549. https:\/\/doi.org\/10.1007\/s11033-020-06087-x","journal-title":"Mol Biol Rep"},{"key":"11976_CR36","doi-asserted-by":"publisher","first-page":"10589","DOI":"10.2147\/DDDT.S554844","volume":"19","author":"P Pandey","year":"2025","unstructured":"Pandey P, Alkhathami AG, Saeed M et al (2025) Molecular Insights into Phytochemicals Mediated Epigenetic Regulation in Preclinical Models of Breast Cancer. Drug Des Devel Ther 19:10589\u201310606. https:\/\/doi.org\/10.2147\/DDDT.S554844","journal-title":"Drug Des Devel Ther"},{"key":"11976_CR37","doi-asserted-by":"publisher","unstructured":"Jiang W, Xia T, Liu C et al (2021) Remodeling the Epigenetic Landscape of Cancer\u2014Application Potential of Flavonoids in the Prevention and Treatment of Cancer. https:\/\/doi.org\/10.3389\/fonc.2021.705903. Front Oncol 11-2021","DOI":"10.3389\/fonc.2021.705903"},{"key":"11976_CR38","unstructured":"Bishayee A, Bhatia D (2018) Epigenetics of Cancer prevention. Academic"},{"key":"11976_CR39","unstructured":"Bahare Salehi AV MS-R, DK, JS-R The Therapeutic Potential of Apigenin"},{"key":"11976_CR40","unstructured":"Bishayee A et al Epigenetics of Cancer Prevention"},{"key":"11976_CR41","doi-asserted-by":"publisher","unstructured":"Bao Y, Wu X, Jin X et al (2022) Apigenin inhibits renal cell carcinoma cell proliferation through G2\/M phase cell cycle arrest. Oncol Rep 47. https:\/\/doi.org\/10.3892\/or.2022.8271","DOI":"10.3892\/or.2022.8271"},{"key":"11976_CR42","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1007\/s12672-022-00505-1","volume":"13","author":"SST Hnit","year":"2022","unstructured":"Hnit SST, Yao M, Xie C et al (2022) Apigenin impedes cell cycle progression at G2 phase in prostate cancer cells. Discover Oncol 13:44. https:\/\/doi.org\/10.1007\/s12672-022-00505-1","journal-title":"Discover Oncol"},{"key":"11976_CR43","doi-asserted-by":"publisher","first-page":"434","DOI":"10.1002\/tox.22247","volume":"32","author":"T Tseng","year":"2017","unstructured":"Tseng T, Chien M, Lin W et al (2017) Inhibition of MDA-MB\u2010231 breast cancer cell proliferation and tumor growth by apigenin through induction of G2\/M arrest and histone H3 acetylation\u2010mediated p21WAF1\/CIP1 expression. Environ Toxicol 32:434\u2013444","journal-title":"Environ Toxicol"},{"key":"11976_CR44","doi-asserted-by":"publisher","unstructured":"Kaewmanee M, Limpaiboon T, Ngernyuang N (2025) Apigenin Induces Apoptosis and Inhibits Migration in Human Cholangiocarcinoma Cells. Toxics 13. https:\/\/doi.org\/10.3390\/toxics13020112","DOI":"10.3390\/toxics13020112"},{"key":"11976_CR45","doi-asserted-by":"publisher","unstructured":"Kim TW, Lee HG (2021) Apigenin Induces Autophagy and Cell Death by Targeting EZH2 under Hypoxia Conditions in Gastric Cancer Cells. Int J Mol Sci 22. https:\/\/doi.org\/10.3390\/ijms222413455","DOI":"10.3390\/ijms222413455"},{"key":"11976_CR46","doi-asserted-by":"publisher","first-page":"292","DOI":"10.4149\/neo_2021_210615N798","volume":"69","author":"J Zeng","year":"2022","unstructured":"Zeng J, Xie H, Zhang Z-L et al (2022) Apigenin regulates the migration, invasion, and autophagy of hepatocellular carcinoma cells by downregulating YAP. Neoplasma 69:292\u2013302. https:\/\/doi.org\/10.4149\/neo_2021_210615N798","journal-title":"Neoplasma"},{"key":"11976_CR47","doi-asserted-by":"publisher","unstructured":"Li S, Hao L, Li N et al (2024) Targeting the Hippo\/YAP1 signaling pathway in hepatocellular carcinoma: From mechanisms to therapeutic drugs (Review). Int J Oncol 65. https:\/\/doi.org\/10.3892\/ijo.2024.5676","DOI":"10.3892\/ijo.2024.5676"},{"key":"11976_CR48","doi-asserted-by":"publisher","first-page":"114375","DOI":"10.1016\/j.biopha.2023.114375","volume":"160","author":"M Kulaphisit","year":"2023","unstructured":"Kulaphisit M, Pomlok K, Saenjum C et al (2023) The anti-leukemic activity of a luteolin-apigenin enriched fraction from an edible and ethnomedicinal plant, Elsholtzia stachyodes, is exerted through an ER stress\/autophagy\/cell cycle arrest\/ apoptotic cell death signaling axis. Biomed Pharmacother 160:114375. https:\/\/doi.org\/10.1016\/j.biopha.2023.114375","journal-title":"Biomed Pharmacother"},{"key":"11976_CR49","doi-asserted-by":"publisher","first-page":"212","DOI":"10.3978\/j.issn.1000-9604.2013.04.01","volume":"25","author":"X Cao","year":"2013","unstructured":"Cao X, Liu B, Cao W et al (2013) Autophagy inhibition enhances apigenin-induced apoptosis in human breast cancer cells. Chin J Cancer Res 25:212\u2013222. https:\/\/doi.org\/10.3978\/j.issn.1000-9604.2013.04.01","journal-title":"Chin J Cancer Res"},{"key":"11976_CR50","doi-asserted-by":"publisher","first-page":"1599","DOI":"10.3892\/ijo.2014.2339","volume":"44","author":"Y Lee","year":"2014","unstructured":"Lee Y, Sung B, Kang YJ et al (2014) Apigenin-induced apoptosis is enhanced by inhibition of autophagy formation in HCT116 human colon cancer cells. Int J Oncol 44:1599\u20131606. https:\/\/doi.org\/10.3892\/ijo.2014.2339","journal-title":"Int J Oncol"},{"key":"11976_CR51","doi-asserted-by":"publisher","first-page":"960","DOI":"10.1097\/CAD.0000000000000413","volume":"27","author":"PLC Coelho","year":"2016","unstructured":"Coelho PLC, Oliveira MN, Da Silva AB et al (2016) The flavonoid apigenin from Croton betulaster Mull inhibits proliferation, induces differentiation and regulates the inflammatory profile of glioma cells. Anticancer Drugs 27:960\u2013969. https:\/\/doi.org\/10.1097\/CAD.0000000000000413","journal-title":"Anticancer Drugs"},{"key":"11976_CR52","doi-asserted-by":"publisher","unstructured":"Abid R, Ghazanfar S, Farid A et al (2022) Pharmacological Properties of 4\u2019, 5, 7-Trihydroxyflavone (Apigenin) and Its Impact on Cell Signaling Pathways. Molecules 27. https:\/\/doi.org\/10.3390\/molecules27134304","DOI":"10.3390\/molecules27134304"},{"key":"11976_CR53","doi-asserted-by":"publisher","first-page":"156519","DOI":"10.1016\/j.phymed.2025.156519","volume":"139","author":"P Gongpan","year":"2025","unstructured":"Gongpan P, Xu T, Zhang Y et al (2025) Apigenin alleviates inflammation as a natural IRAK4 inhibitor. Phytomedicine 139:156519. https:\/\/doi.org\/10.1016\/j.phymed.2025.156519","journal-title":"Phytomedicine"},{"key":"11976_CR54","doi-asserted-by":"publisher","first-page":"13965","DOI":"10.2147\/JIR.S549251","volume":"18","author":"Z Wu","year":"2025","unstructured":"Wu Z, Fang Y, Dong Y et al (2025) Apigenin Suppresses NLRP3 Inflammasome Activation and Pyroptosis and Promotes Functional Recovery by Promoting Mitophagy in Experimental Spinal Cord Injured Rats. J Inflamm Res 18:13965\u201313984. https:\/\/doi.org\/10.2147\/JIR.S549251","journal-title":"J Inflamm Res"},{"key":"11976_CR55","unstructured":"Singh Y MAMBSP Epigenetic regulation of PANoptosis: DNA methylation, histone modifications and non-coding RNAs"},{"key":"11976_CR56","doi-asserted-by":"publisher","unstructured":"Gholap AD, Chavda VP, Vaghela DA et al (2024) A Benefaction of Flavonoids as Epigenetic Modulators for Effective Cancer Treatment. https:\/\/doi.org\/10.20944\/preprints202407.0980.v1. Preprints (Basel)","DOI":"10.20944\/preprints202407.0980.v1"},{"key":"11976_CR57","doi-asserted-by":"publisher","unstructured":"Liu K, Li Y, Shen M et al (2025) Epigenetic Regulation of Stromal and Immune Cells and Therapeutic Targets in the Tumor Microenvironment. Biomolecules 15. https:\/\/doi.org\/10.3390\/biom15010071","DOI":"10.3390\/biom15010071"},{"key":"11976_CR58","doi-asserted-by":"publisher","unstructured":"Cord D, R\u00eembu MC, Iordache MP et al (2025) Phytochemicals as Epigenetic Modulators in Chronic Diseases: Molecular Mechanisms. Molecules 30. https:\/\/doi.org\/10.3390\/molecules30214317","DOI":"10.3390\/molecules30214317"},{"key":"11976_CR59","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1186\/s40779-022-00378-z","volume":"9","author":"X Lin","year":"2022","unstructured":"Lin X, Wang F, Chen J et al (2022) N6-methyladenosine modification of CENPK mRNA by ZC3H13 promotes cervical cancer stemness and chemoresistance. Mil Med Res 9:19. https:\/\/doi.org\/10.1186\/s40779-022-00378-z","journal-title":"Mil Med Res"},{"key":"11976_CR60","doi-asserted-by":"publisher","first-page":"774","DOI":"10.1002\/iub.2456","volume":"73","author":"X Zhang","year":"2021","unstructured":"Zhang X, Zhang W, Chen F, Lu Z (2021) Combined effect of chrysin and apigenin on inhibiting the development and progression of colorectal cancer by suppressing the activity of P38-MAPK\/AKT pathway. IUBMB Life 73:774\u2013783. https:\/\/doi.org\/10.1002\/iub.2456","journal-title":"IUBMB Life"},{"key":"11976_CR61","doi-asserted-by":"publisher","first-page":"5241","DOI":"10.1002\/ptr.7197","volume":"35","author":"MCS Mancini","year":"2021","unstructured":"Mancini MCS, Ponte LGS, Silva CHR et al (2021) Beetroot and leaf extracts present protective effects against prostate cancer cells, inhibiting cell proliferation, migration, and growth signaling pathways. Phytother Res 35:5241\u20135258. https:\/\/doi.org\/10.1002\/ptr.7197","journal-title":"Phytother Res"},{"key":"11976_CR62","doi-asserted-by":"publisher","unstructured":"Ghanbari-Movahed M, Shafiee S, Burcher JT et al (2023) Anticancer Potential of Apigenin and Isovitexin with Focus on Oncogenic Metabolism in Cancer Stem Cells. Metabolites 13. https:\/\/doi.org\/10.3390\/metabo13030404","DOI":"10.3390\/metabo13030404"},{"key":"11976_CR63","doi-asserted-by":"publisher","first-page":"116566","DOI":"10.1016\/j.biopha.2024.116566","volume":"174","author":"S Wang","year":"2024","unstructured":"Wang S, He Y, Wang J, Luo E (2024) Re-exploration of immunotherapy targeting EMT of hepatocellular carcinoma: Starting from the NF-\u03baB pathway. Biomed Pharmacother 174:116566. https:\/\/doi.org\/10.1016\/j.biopha.2024.116566","journal-title":"Biomed Pharmacother"},{"key":"11976_CR64","doi-asserted-by":"publisher","first-page":"583","DOI":"10.1002\/kjm2.12370","volume":"37","author":"X Zhao","year":"2021","unstructured":"Zhao X, Zhou H-B, Liu J et al (2021) Apigenin suppresses proliferation, invasion, and epithelial-mesenchymal transition of cervical carcinoma cells by regulation of miR-152\/BRD4 axis. Kaohsiung J Med Sci 37:583\u2013593. https:\/\/doi.org\/10.1002\/kjm2.12370","journal-title":"Kaohsiung J Med Sci"},{"key":"11976_CR65","doi-asserted-by":"publisher","unstructured":"Cao HH, Chu JH, Kwan HY et al (2016) Inhibition of the STAT3 signaling pathway contributes to apigenin-mediated anti-metastatic effect in melanoma. Sci Rep 6. https:\/\/doi.org\/10.1038\/srep21731","DOI":"10.1038\/srep21731"},{"key":"11976_CR66","doi-asserted-by":"publisher","unstructured":"Nimal S, Kumbhar N, Saruchi et al (2024) Apigenin and its combination with Vorinostat induces apoptotic-mediated cell death in TNBC by modulating the epigenetic and apoptotic regulators and related miRNAs. Sci Rep 14, 9540. https:\/\/doi.org\/10.1038\/s41598-024-60395-x","DOI":"10.1038\/s41598-024-60395-x"},{"key":"11976_CR67","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1186\/s12929-025-01167-1","volume":"32","author":"B-S Pan","year":"2025","unstructured":"Pan B-S, Hsu C-C, Wu H-E et al (2025) Glucose metabolism and its direct action in cancer and immune regulation: opportunities and challenges for metabolic targeting. J Biomed Sci 32:71. https:\/\/doi.org\/10.1186\/s12929-025-01167-1","journal-title":"J Biomed Sci"},{"key":"11976_CR68","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1007\/s12032-021-01586-8","volume":"38","author":"Y Zhao","year":"2021","unstructured":"Zhao Y, Huang H, Jia C-H et al (2021) Apigenin increases radiosensitivity of glioma stem cells by attenuating HIF-1\u03b1-mediated glycolysis. Med Oncol 38:131. https:\/\/doi.org\/10.1007\/s12032-021-01586-8","journal-title":"Med Oncol"},{"key":"11976_CR69","doi-asserted-by":"publisher","first-page":"1094480","DOI":"10.3389\/fonc.2023.1094480","volume":"13","author":"TH Kim","year":"2023","unstructured":"Kim TH, Kwak Y, Song C et al (2023) GLUT-1 may predict metastases and death in patients with locally advanced rectal cancer. Front Oncol 13:1094480. https:\/\/doi.org\/10.3389\/fonc.2023.1094480","journal-title":"Front Oncol"},{"key":"11976_CR70","doi-asserted-by":"publisher","first-page":"116626","DOI":"10.1016\/j.taap.2023.116626","volume":"475","author":"S Heydarzadeh","year":"2023","unstructured":"Heydarzadeh S, Moshtaghie AA, Daneshpour M, Hedayati M (2023) The effect of Apigenin on glycometabolism and cell death in an anaplastic thyroid cancer cell line. Toxicol Appl Pharmacol 475:116626. https:\/\/doi.org\/10.1016\/j.taap.2023.116626","journal-title":"Toxicol Appl Pharmacol"},{"key":"11976_CR71","doi-asserted-by":"publisher","first-page":"3983637","DOI":"10.1155\/2022\/3983637","volume":"2022","author":"Y Shi","year":"2022","unstructured":"Shi Y, Lian K, Jia J (2022) Apigenin Suppresses the Warburg Effect and Stem-like Properties in SOSP-9607 Cells by Inactivating the PI3K\/Akt\/mTOR Signaling Pathway. Evid Based Complement Alternat Med 2022:3983637. https:\/\/doi.org\/10.1155\/2022\/3983637","journal-title":"Evid Based Complement Alternat Med"},{"key":"11976_CR72","doi-asserted-by":"publisher","unstructured":"Bhosale PB, Jeong SH, Kim HH et al (2025) Therapeutic Potential and Cancer Cell Death-Inducing Effects of Apigenin and Its Derivatives. Int J Mol Sci 26. https:\/\/doi.org\/10.3390\/ijms262010084","DOI":"10.3390\/ijms262010084"},{"key":"11976_CR73","doi-asserted-by":"publisher","unstructured":"Lee Y-J, Park K-S, Heo S-H et al (2023) Concurrent induction of apoptosis and necroptosis in apigenin-treated malignant mesothelioma cells: Reversal of Warburg effect through Akt inhibition and p53 upregulation. Oncol Rep 49. https:\/\/doi.org\/10.3892\/or.2023.8548","DOI":"10.3892\/or.2023.8548"},{"key":"11976_CR74","doi-asserted-by":"publisher","unstructured":"Ragusa MA, Gentile C, Nicosia A et al (2025) Epigenetic Remodeling of Regulatory Regions by Indicaxanthin Suggests a Shift in Cell Identity Programs in Colorectal Cancer Cells. Int J Mol Sci 26. https:\/\/doi.org\/10.3390\/ijms26136072","DOI":"10.3390\/ijms26136072"},{"key":"11976_CR75","doi-asserted-by":"publisher","first-page":"952","DOI":"10.1002\/mc.20866","volume":"51","author":"M Pandey","year":"2012","unstructured":"Pandey M, Kaur P, Shukla S et al (2012) Plant flavone apigenin inhibits HDAC and remodels chromatin to induce growth arrest and apoptosis in human prostate cancer cells: In vitro and in vivo study. Mol Carcinog 51:952\u2013962. https:\/\/doi.org\/10.1002\/mc.20866","journal-title":"Mol Carcinog"},{"key":"11976_CR76","doi-asserted-by":"publisher","first-page":"9705","DOI":"10.1080\/07391102.2023.2272743","volume":"42","author":"SM Borah","year":"2024","unstructured":"Borah SM, Kma L, Darjee MS et al (2024) Apigenin promotes cell death in NCI-H23 cells by upregulation of PTEN: potential involvement of the binding of apigenin with WWP2 protein. J Biomol Struct Dyn 42:9705\u20139719. https:\/\/doi.org\/10.1080\/07391102.2023.2272743","journal-title":"J Biomol Struct Dyn"},{"key":"11976_CR77","doi-asserted-by":"publisher","first-page":"20220819","DOI":"10.1515\/biol-2022-0819","volume":"19","author":"Y Li","year":"2024","unstructured":"Li Y, Man X, Zhang Q et al (2024) Apigenin 7-glucoside impedes hypoxia-induced malignant phenotypes of cervical cancer cells in a p16-dependent manner. Open Life Sci 19:20220819. https:\/\/doi.org\/10.1515\/biol-2022-0819","journal-title":"Open Life Sci"},{"key":"11976_CR78","doi-asserted-by":"publisher","first-page":"1569","DOI":"10.1007\/s11010-022-04363-x","volume":"477","author":"Q Xie","year":"2022","unstructured":"Xie Q, Zhang R, Liu D et al (2022) Apigenin inhibits growth of melanoma by suppressing miR-512-3p and promoting the G1 phase of cell cycle involving the p27 Kip1 protein. Mol Cell Biochem 477:1569\u20131582. https:\/\/doi.org\/10.1007\/s11010-022-04363-x","journal-title":"Mol Cell Biochem"},{"key":"11976_CR79","doi-asserted-by":"publisher","first-page":"8264","DOI":"10.3390\/ijms25158264","volume":"25","author":"S Gupta","year":"2024","unstructured":"Gupta S, Silveira DA, Lorenzoni PR et al (2024) LncRNA PTENP1\/miR-21\/PTEN Axis Modulates EMT and Drug Resistance in Cancer: Dynamic Boolean Modeling for Cell Fates in DNA Damage Response. Int J Mol Sci 25:8264. https:\/\/doi.org\/10.3390\/ijms25158264","journal-title":"Int J Mol Sci"},{"key":"11976_CR80","doi-asserted-by":"publisher","unstructured":"Xie Y, Liang D, Wu Q et al (2019) A System-Level Investigation into the Mechanisms of Apigenin Against Inflammation. Nat Prod Commun 14. https:\/\/doi.org\/10.1177\/1934578X19878600","DOI":"10.1177\/1934578X19878600"},{"key":"11976_CR81","doi-asserted-by":"publisher","unstructured":"Ganai SA, Farooq Z, Banday S, Altaf M (2018) In silico approaches for investigating the binding propensity of apigenin and luteolin against class I HDAC isoforms. Future Med Chem 1, 10(16):1925\u20131945. https:\/\/doi.org\/10.4155\/fmc-2018-0020","DOI":"10.4155\/fmc-2018-0020"},{"key":"11976_CR82","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1007\/s12551-016-0247-1","volume":"9","author":"NS Pagadala","year":"2017","unstructured":"Pagadala NS, Syed K, Tuszynski J (2017) Software for molecular docking: a review. Biophys Rev 9:91\u2013102","journal-title":"Biophys Rev"},{"key":"11976_CR83","doi-asserted-by":"publisher","first-page":"W159","DOI":"10.1093\/nar\/gkac394","volume":"50","author":"Y Liu","year":"2022","unstructured":"Liu Y, Yang X, Gan J et al (2022) CB-Dock2: improved protein-ligand blind docking by integrating cavity detection, docking and homologous template fitting. Nucleic Acids Res 50:W159\u2013W164. https:\/\/doi.org\/10.1093\/nar\/gkac394","journal-title":"Nucleic Acids Res"},{"key":"11976_CR84","doi-asserted-by":"publisher","DOI":"10.1016\/j.compbiomed.2021.104683","author":"S Murugesan","year":"2021","unstructured":"Murugesan S, Kottekad S, Crasta I et al (2021) Targeting COVID-19 (SARS-CoV-2) main protease through active phytocompounds of ayurvedic medicinal plants \u2013 Emblica officinalis (Amla), Phyllanthus niruri Linn. (Bhumi Amla) and Tinospora cordifolia (Giloy) \u2013 A molecular docking and simulation study. Comput Biol Med. https:\/\/doi.org\/10.1016\/j.compbiomed.2021.104683. 136:","journal-title":"Comput Biol Med"},{"key":"11976_CR85","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1016\/j.sbi.2007.12.007","volume":"18","author":"WF van Gunsteren","year":"2008","unstructured":"van Gunsteren WF, Dolenc J, Mark AE (2008) Molecular simulation as an aid to experimentalists. Curr Opin Struct Biol 18:149\u2013153. https:\/\/doi.org\/10.1016\/j.sbi.2007.12.007","journal-title":"Curr Opin Struct Biol"},{"key":"11976_CR86","doi-asserted-by":"publisher","unstructured":"Cheng Y, Han X, Mo F, Zeng H, Zhao Y, Wang H, Zheng Y, Ma X (2021) Apigenin inhibits the growth of colorectal cancer through down-regulation of E2F1\/3 by miRNA-215-5p. Phytomedicine 89:153603. https:\/\/doi.org\/10.1016\/j.phymed.2021.153603","DOI":"10.1016\/j.phymed.2021.153603"},{"key":"11976_CR87","doi-asserted-by":"publisher","unstructured":"Darwiche N (2020) Epigenetic mechanisms and the hallmarks of cancer: an intimate affair. Am J Cancer Res 2020 Jul 1, 10(7):1954\u20131978. https:\/\/doi.org\/10.1371\/journal.pgen.1007362","DOI":"10.1371\/journal.pgen.1007362"},{"key":"11976_CR88","doi-asserted-by":"publisher","unstructured":"Hong S, Dia VP, Baek SJ, Zhong Q (2022) Nanoencapsulation of apigenin with whey protein isolate: physicochemical properties, in vitro activity against colorectal cancer cells, and bioavailability. Lebensm Wiss Technol 154. https:\/\/doi.org\/10.1016\/j.lwt.2021.112751","DOI":"10.1016\/j.lwt.2021.112751"},{"key":"11976_CR89","doi-asserted-by":"publisher","first-page":"681477","DOI":"10.3389\/fphar.2021.681477","volume":"12","author":"EF DeRango-Adem","year":"2021","unstructured":"DeRango-Adem EF, Blay J (2021) Does Oral Apigenin Have Real Potential for a Therapeutic Effect in the Context of Human Gastrointestinal and Other Cancers? Front Pharmacol 12:681477. https:\/\/doi.org\/10.3389\/fphar.2021.681477","journal-title":"Front Pharmacol"},{"key":"11976_CR90","doi-asserted-by":"publisher","first-page":"5071","DOI":"10.19540\/j.cnki.cjcmm.20220421.702","volume":"47","author":"L-L Li","year":"2022","unstructured":"Li L-L, Huang Q, Qi J-J et al (2022) [Simultaneous determination and pharmacokinetic study of five compounds from total extract of Clinopodium chinense in abnormal uterine bleeding rat plasma by UPLC-MS\/MS]. Zhongguo Zhong Yao Za Zhi 47:5071\u20135078. https:\/\/doi.org\/10.19540\/j.cnki.cjcmm.20220421.702","journal-title":"Zhongguo Zhong Yao Za Zhi"},{"key":"11976_CR91","doi-asserted-by":"publisher","first-page":"1920","DOI":"10.1021\/acs.molpharmaceut.0c00977","volume":"18","author":"R Sen","year":"2021","unstructured":"Sen R, Ganguly S, Ganguly S et al (2021) Apigenin-Loaded PLGA-DMSA Nanoparticles: A Novel Strategy to Treat Melanoma Lung Metastasis. Mol Pharm 18:1920\u20131938. https:\/\/doi.org\/10.1021\/acs.molpharmaceut.0c00977","journal-title":"Mol Pharm"},{"key":"11976_CR92","doi-asserted-by":"publisher","DOI":"10.3389\/fchem.2020.00829","author":"M Ashrafizadeh","year":"2020","unstructured":"Ashrafizadeh M, Bakhoda MR, Bahmanpour Z et al (2020) Apigenin as Tumor Suppressor in Cancers: Biotherapeutic Activity, Nanodelivery, and Mechanisms With Emphasis on Pancreatic Cancer. Front Chem Volume. https:\/\/doi.org\/10.3389\/fchem.2020.00829. 8-2020","journal-title":"Front Chem Volume"},{"key":"11976_CR93","doi-asserted-by":"publisher","unstructured":"Dalbanjan NP, Korgaonkar K, Eelager MP et al (2025) In-silico strategies in nano-drug design: Bridging nanomaterials and pharmacological applications. Nano TransMed 4, 100091. https:\/\/doi.org\/10.1016\/j.ntm.2025.100091","DOI":"10.1016\/j.ntm.2025.100091"},{"key":"11976_CR94","doi-asserted-by":"crossref","unstructured":"Sharifi-Rad J, Quispe C, Butnariu M et al (2021) Chitosan nanoparticles as a promising tool in nanomedicine with particular emphasis on oncological treatment. Cancer Cell Int 21:318","DOI":"10.1186\/s12935-021-02025-4"},{"key":"11976_CR95","doi-asserted-by":"publisher","unstructured":"Porfire A, Achim M, Tefas L, Sylvester B (2017) Liposomal Nanoformulations as Current Tumor-Targeting Approach to Cancer Therapy. In: Catala A (ed) Liposomes. IntechOpen. https:\/\/doi.org\/10.5772\/intechopen.68160","DOI":"10.5772\/intechopen.68160"},{"key":"11976_CR96","doi-asserted-by":"publisher","unstructured":"Khan S, Hussain A, Attar F et al (2022) A review of the berberine natural polysaccharide nanostructures as potential anticancer and antibacterial agents. Biomed Pharmacotherapy 146, 112531. https:\/\/doi.org\/10.1016\/j.biopha.2021.112531","DOI":"10.1016\/j.biopha.2021.112531"},{"key":"11976_CR97","doi-asserted-by":"publisher","first-page":"1513","DOI":"10.1021\/acsptsci.5c00162","volume":"8","author":"K Mehta","year":"2025","unstructured":"Mehta K, Maass C, Cucurull-Sanchez L et al (2025) Modernizing Preclinical Drug Development: The Role of New Approach Methodologies. ACS Pharmacol Transl Sci 8:1513\u20131525. https:\/\/doi.org\/10.1021\/acsptsci.5c00162","journal-title":"ACS Pharmacol Transl Sci"},{"key":"11976_CR98","doi-asserted-by":"publisher","first-page":"6600","DOI":"10.3390\/cimb46070393","volume":"46","author":"RF Abutayeh","year":"2024","unstructured":"Abutayeh RF, Altah M, Mehdawi A et al (2024) Chemopreventive Agents from Nature: A Review of Apigenin, Rosmarinic Acid, and Thymoquinone. Curr Issues Mol Biol 46:6600\u20136619","journal-title":"Curr Issues Mol Biol"},{"key":"11976_CR99","doi-asserted-by":"publisher","unstructured":"Dong L, Yang F, Wang X et al (2025) Apigenin combined with cisplatin suppressed the progression of colorectal cancer by targeting the KRT23\/Wnt\/\u03b2-catenin signaling pathway. Discover Oncol 16. https:\/\/doi.org\/10.1007\/s12672-025-03942-w","DOI":"10.1007\/s12672-025-03942-w"},{"key":"11976_CR100","doi-asserted-by":"publisher","unstructured":"Mahbub AA, Le Maitre CL, Cross NA, Jordan-Mahy N. (2022). The effect of apigenin and chemotherapy combination treatments on apoptosis-related genes and proteins in acute leukaemia cell lines. Sci Rep 25, 12(1):8858. https:\/\/doi.org\/10.1038\/s41598-022-11441-z","DOI":"10.1038\/s41598-022-11441-z"}],"container-title":["Molecular Biology Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11033-026-11976-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11033-026-11976-8","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11033-026-11976-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,26]],"date-time":"2026-05-26T11:31:33Z","timestamp":1779795093000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11033-026-11976-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,26]]},"references-count":100,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,12]]}},"alternative-id":["11976"],"URL":"https:\/\/doi.org\/10.1007\/s11033-026-11976-8","relation":{},"ISSN":["0301-4851","1573-4978"],"issn-type":[{"value":"0301-4851","type":"print"},{"value":"1573-4978","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,26]]},"assertion":[{"value":"14 February 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 May 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 May 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Not applicable \u2013 this manuscript is a review article and does not report on or involve the use of any human participants, human data, or animal data.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics declarations"}}],"article-number":"827"}}